OBJECTIVE: To critically review the use of beta-adrenergic agonists in acute, severe asthma
with particular focus on aerosol administration. DATA SOURCES: English language articles …

Beta2 adrenergic agonists, especially in aerosol formulations, are often used as first-line
medications for treating the symptoms of bronchial asthma. Although oral forms of these …

In the last decade, the development of safer, more effective, and longer acting beta2-
adenergic drugs has provided physicians with the means of both preventing and treating …

Adrenergic drugs are the agents of choice for treatment of acute asthma. Aerosol
administration delivers the drug directly to the airways, is effective in substantially lower …

Short acting beta-agonists provide symptom relief with a rapid onset of bronchodilation, and
protect against exercise-induced asthma and the early asthmatic response to allergen. They …

The introduction of selective, potent inhaled β2-agonists more than 30 years ago
revolutionized the treatment of asthma. Until that time, nonselective sympathomimetic …

Conclusion The introduction of long-acting inhaled β 2-agonists has been a major
therapeutic development, and has led to a fundamental reappraisal of β 2-agonist use in …

The principles of aerosol drug delivery by compressed-air nebulization are described, and
the therapeutic agents administered by this process for management of asthma are …

Nebulized salbutamol has been known to be an effective treatment of asthma for almost two
decades [1] and nebulized bronchodilator therapy has now become firstline treatment of …

Abstract Asthma-mortality Prevalence Bronchodilator Agents-administration & dosage
Glucocorticoids Humans Administration, Inhalation Asthma-drug therapy Time Factors …